WO2001051632A3 - Nouveaux polypeptides et acides nucleiques codant pour ceux-ci - Google Patents

Nouveaux polypeptides et acides nucleiques codant pour ceux-ci Download PDF

Info

Publication number
WO2001051632A3
WO2001051632A3 PCT/US2001/001513 US0101513W WO0151632A3 WO 2001051632 A3 WO2001051632 A3 WO 2001051632A3 US 0101513 W US0101513 W US 0101513W WO 0151632 A3 WO0151632 A3 WO 0151632A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
acids encoding
novx
receptor polypeptides
encoding same
Prior art date
Application number
PCT/US2001/001513
Other languages
English (en)
Other versions
WO2001051632A2 (fr
WO2001051632A9 (fr
Inventor
Muralidhar Padigaru
Sudhirdas K Prayaga
Raymond J Taupier Jr
Vishnu Mishra
Velizar T Tchernev
Kimberley A Spytek
Li Li
Original Assignee
Curagen Corp
Muralidhar Padigaru
Sudhirdas K Prayaga
Raymond J Taupier Jr
Vishnu Mishra
Velizar T Tchernev
Kimberley A Spytek
Li Li
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curagen Corp, Muralidhar Padigaru, Sudhirdas K Prayaga, Raymond J Taupier Jr, Vishnu Mishra, Velizar T Tchernev, Kimberley A Spytek, Li Li filed Critical Curagen Corp
Priority to AU2001227925A priority Critical patent/AU2001227925A1/en
Publication of WO2001051632A2 publication Critical patent/WO2001051632A2/fr
Publication of WO2001051632A3 publication Critical patent/WO2001051632A3/fr
Publication of WO2001051632A9 publication Critical patent/WO2001051632A9/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention concerne de nouveaux polynucléotides NOVX isolés et des polypeptides codés par les polynucléotides NOVX. L'invention concerne également des anticorps de liaison immunospécifique à un polypeptide NOVX ou à tout dérivé, variant, mutant ou fragment du polypeptide, du polynucléotide ou de l'anticorps NOVX. L'invention concerne en outre des méthodes dans lesquelles le polypeptide, le polynucléotide et l'anticorps NOVX sont utilisés pour la détection et le traitement d'une grande variété d'états pathologiques, ainsi que pour d'autres utilisations.
PCT/US2001/001513 2000-01-13 2001-01-16 Nouveaux polypeptides et acides nucleiques codant pour ceux-ci WO2001051632A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001227925A AU2001227925A1 (en) 2000-01-13 2001-01-16 Odorant receptor polypeptides and nucleic acids encoding same

Applications Claiming Priority (16)

Application Number Priority Date Filing Date Title
US17598900P 2000-01-13 2000-01-13
US60/175,989 2000-01-13
US17613400P 2000-01-14 2000-01-14
US60/176,134 2000-01-14
US17783900P 2000-01-25 2000-01-25
US60/177,839 2000-01-25
US17819100P 2000-01-26 2000-01-26
US17822700P 2000-01-26 2000-01-26
US60/178,227 2000-01-26
US60/178,191 2000-01-26
US21832400P 2000-07-14 2000-07-14
US60/218,324 2000-07-14
US22025300P 2000-07-24 2000-07-24
US60/220,253 2000-07-24
US22059000P 2000-07-25 2000-07-25
US60/220,590 2000-07-25

Publications (3)

Publication Number Publication Date
WO2001051632A2 WO2001051632A2 (fr) 2001-07-19
WO2001051632A3 true WO2001051632A3 (fr) 2002-04-18
WO2001051632A9 WO2001051632A9 (fr) 2002-10-31

Family

ID=27575063

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/001513 WO2001051632A2 (fr) 2000-01-13 2001-01-16 Nouveaux polypeptides et acides nucleiques codant pour ceux-ci

Country Status (2)

Country Link
AU (1) AU2001227925A1 (fr)
WO (1) WO2001051632A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002014501A2 (fr) * 2000-08-17 2002-02-21 Agensys, Inc. Acides nucleiques et proteines correspondantes appelees phor1-a11 et phor1-f5d6 utiles dans le traitement et la detection du cancer
WO2002050276A2 (fr) * 2000-12-18 2002-06-27 Curagen Corporation Nouvelle proteine et acides nucleiques codant pour celle-ci

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992017585A1 (fr) * 1991-04-05 1992-10-15 The Trustees Of Columbia University In The City Of New York Recepteurs de substances odorantes et leurs utilisations

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992017585A1 (fr) * 1991-04-05 1992-10-15 The Trustees Of Columbia University In The City Of New York Recepteurs de substances odorantes et leurs utilisations

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 15 October 1999 (1999-10-15), PIETER DE JONG: "Human DNA sequence from clone RP1-313I6 on chromosome 6. Contains a KIAA0036 pseudogene, olfactory receptor 2W2, 2B7, 2B8 and 1F12 pseudogenes (OR2W2P, OR2B7P, OR2B8 and OR1F12), the ZNF165 gene for zinc finger protein 165, two zinc finger protein pseudogenes, ESTs, STSs, GSSs and two CpG islands.", XP002182046, retrieved from EBI Database accession no. AL121944 *
DATABASE EMBL [online] 8 October 1999 (1999-10-08), BIRREN B. ET AL.: "Homo sapiens clone RP11-12E10, WORKING DRAFT SEQUENCE, 27 unordered pieces.", XP002182047, retrieved from EBI Database accession no. AC011571 *

Also Published As

Publication number Publication date
WO2001051632A2 (fr) 2001-07-19
AU2001227925A1 (en) 2001-07-24
WO2001051632A9 (fr) 2002-10-31

Similar Documents

Publication Publication Date Title
WO2001092523A3 (fr) Nouveaux polynucleotides humains et polypeptides codes par ceux-ci
WO2000058473A3 (fr) Acides nucleiques comprenant des phases de lecture ouverte codant des polypeptides; «orfx»
WO2001007595A3 (fr) Nouveau facteur de croissance des fibroblastes et acides nucleiques codant ce dernier
WO2001036645A3 (fr) Nouveaux polypeptides et acides nucleiques codant les memes
WO2004048521A3 (fr) Composition et procede pour traiter la nephropathie lupique
MXPA03006218A (es) Receptor de citosina tipo 2 y acidos nucleicos que codifican para lo mismo.
WO2000053742A3 (fr) Polynucleotides et proteines codees par ceux-ci
WO2001049729A3 (fr) Nouveaux polypeptides et acides nucleiques codant ceux-ci
WO2001074856A3 (fr) Polypeptides de type wnt-7b et acides nucleiques codant pour ceux-ci
WO2001070978A3 (fr) Nouveaux polypeptides et acides nucleiques codant ces polypeptides
WO2001062928A3 (fr) Polypeptides et acides nucleiques codant pour
WO2002002625A3 (fr) Nouveaux facteurs de croissance des fibroblastes et acides nucleiques codant pour ces memes facteurs
WO2001061009A3 (fr) Nouveaux polypeptides et acides nucleiques les codant
WO2003025147A3 (fr) Nouveaux polynucleotides et proteines codees par ceux-ci
WO2001036638A3 (fr) Nouveaux polypeptides et acides nucleiques codant pour ces polypeptides
WO2001044473A3 (fr) Polypeptides et acides nucleiques codant pour ces polypeptides
WO2000061754A3 (fr) Nouvelles proteines humaines et polypeptides codant pour ces proteines
WO2001068851A3 (fr) Nouveaux polypeptides et acides nucleiques les codant
WO2000070046A3 (fr) Nouveaux polypeptides et polynucleotides les codant
WO2003040345A3 (fr) Recepteur de cytokine de type 2 et acides nucleiques codant ce dernier
WO2001023561A3 (fr) Nouveaux polynucleotides codant des proteines contenant des sequences repetees de thrombospondine type 1 (tsrx)
WO2001032874A3 (fr) Nouveaux polypeptides et acides nucleiques les codant
WO2001051632A3 (fr) Nouveaux polypeptides et acides nucleiques codant pour ceux-ci
WO2001023572A3 (fr) Nouveaux polynucleotides et polypeptides codes par ces derniers
WO2000075321A3 (fr) Nouveaux polynucleotides et polypeptides codant pour lesdits polynucleotides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: C2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 133-140, CLAIMS, REPLACED BY NEW PAGES 133-141; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP